Glucocorticoids attenuate haloperidol-induced catalepsy through adrenal catecholamines

Area of Science:

• Neuropharmacology
• Endocrinology
• Behavioral Neuroscience

Background:

• Neuroleptic medications, like haloperidol, can induce catalepsy, a motorImpairment.
• Adrenal secretions, including glucocorticoids and catecholamines, play roles in stress response and neurotransmission.
• The interplay between adrenal function and neuroleptic-induced catalepsy remains incompletely understood.

Purpose of the Study:

• To investigate the impact of adrenal secretions on haloperidol-induced catalepsy.
• To determine the role of corticosterone, noradrenaline, and adrenaline in modulating neuroleptic catalepsy.
• To explore the involvement of alpha-1 adrenoceptors in the anticataleptic effects.

Main Methods:

• Utilized adrenalectomized (ADX) and sham-adrenalectomized (sham-ADX) rats.
• Administered haloperidol to induce catalepsy.
• Tested the effects of corticosterone, dexamethasone, noradrenaline, adrenaline, and cold stress on catalepsy, with and without prazosin (an alpha-1 blocker).

Main Results:

• Adrenalectomized rats exhibited significantly greater haloperidol-induced catalepsy compared to sham-ADX rats.
• Corticosterone and dexamethasone attenuated catalepsy in sham-ADX rats but not in ADX rats.
• Cold stress and corticosterone reduced catalepsy in sham-ADX rats, but not ADX rats; noradrenaline and adrenaline decreased catalepsy in both groups, an effect blocked by prazosin.

Conclusions:

• Peripheral noradrenergic and adrenergic mechanisms are crucial in neuroleptic-induced catalepsy.
• Glucocorticoids may exert their anticataleptic effects by modulating these peripheral adrenergic systems.
• Adrenal status significantly influences the manifestation and modulation of haloperidol-induced catalepsy.